Quince Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$31,385,000 over the previous period. Total operating expenses were $34,620,000.
Profit Margin
| 2017 | 0 | -12.23M | |
|---|---|---|---|
| 2018 | 0 | -12.47M | |
| 2019 | 0 | -36.79M | |
| 2020 | 0 | -76.84M | |
| 2021 | 0 | -89.32M | |
| 2022 | 0 | -51.66M | |
| 2023 | 0 | -31.38M |
QNCX Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 322K | 175K | 344K | 332K | 188K | 0 | 45K |
Gross profit | -322K | -175K | -344K | -332K | -188K | 0 | -45K |
Operating exp. | |||||||
Research and development | 9.44M | 25.17M | 60.79M | 61.30M | 30.21M | 10.08M | 9.09M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 34.62M | 51.19M | 90.31M | 78.89M | 39.16M | 12.11M | 10.37M |
Operating income | -34.62M | -52.01M | -90.31M | -78.89M | -39.16M | -12.11M | -10.37M |
Other income (expenses), net | 3.03M | 71K | 373K | 2.04M | 2.18M | -206K | -1.86M |
Income before tax | -31.58M | -51.94M | -89.94M | -76.84M | -36.98M | -12.47M | -12.23M |
Income tax expense | -197K | -284K | -620K | 2.16M | -188K | 357K | 1.86M |
Net income | -31.38M | -51.66M | -89.32M | -76.84M | -36.79M | -12.47M | -12.23M |
Earnings per share | |||||||
Basic EPS | -0.84 | -1.54 | -3.01 | -2.63 | -1.93 | -0.58 | -0.57 |
Diluted EPS | -0.84 | -1.54 | -3.01 | -2.63 | -1.93 | -0.58 | -0.57 |
| Data source | Data source | Data source | Data source | Data source |